---
$id: https://graph.org.ai/products/commodity/51202413
$type: Product
source: UNSPSC
code: "51202413"
title: "Secukinumab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Secukinumab

**UNSPSC Code**: 51202413
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DLG4EML025, generally known as secukinumab. European Medicines Agency schedules secukinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33242. The term SECUKINUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 1, 2010 List 63). Most nations, for tariff and trade purposes, schedule SECUKINUMAB under HS 29349990 and SITC 51579. SMILES: none.

